Broker Check

Weekly Market Commentary |November 28, 2022



The Markets

There was a shift in the winds of monetary policy.

 

Last week, it became clear the Federal Reserve (Fed) had softened its hawkish stance. The minutes of the central bank’s November policy meeting indicated the Fed was likely to slow the pace of rate hikes soon. There was a caveat, though. The minutes noted:

 

“…with inflation showing little sign thus far of abating, and with supply and demand imbalances in the economy persisting…the ultimate level of the federal funds rate that would be necessary to achieve the Committee’s goals was somewhat higher than [Fed officials] had previously expected.”

 

In other words, rate hikes are likely to be smaller in the future, but the federal funds rate will probably move higher than previously expected. Last week, the CME FedWatch Tool suggested that the federal funds target range will:

 

·         Increase 0.50 percent in December to 4.25 to 4.50 percent.

·         Rise to 5.0 percent to 5.25 percent during 2023.

·         Fall to 4.5 percent to 4.75 percent by the end of next year.

 

Weaker economic data seemed to support the Fed’s pivot. Molly Smith of Bloomberg reported, “Fresh evidence Wednesday pointed to a slowing U.S. economy and a cooling labor market that suggests steep interest-rate hikes by the Federal Reserve are starting to have a broader impact. Business activity contracted for a fifth month in November and applications for unemployment benefits rose last week to a three-month high. While consumer sentiment and new-home sales improved, both remain depressed and indicate a weaker spending appetite and subdued housing demand.”

 

Investors celebrated the Fed’s stance adjustment, and major U.S. stock indices pushed higher last week. Yields on U.S. Treasuries with maturities of one year or less moved higher last week, while yields on longer maturities moved lower.


SHORT TAKES. The Federal Reserve’s pivot wasn’t the only interesting event last week. Here are some other occurrences that may prove to be of interest to investors.

 

A cure for the “Royal disease”. In the 1800s and early 1900s, royalty in Britain, Germany, Russia and Spain suffered from hemophilia, a genetic disorder that prevents blood from clotting. Last week, the U.S. Food and Drug Administration approved the first gene therapy treatment for hemophilia. The treatment, which is administered once, has a price tag of $3.5 million. Cell and gene therapies are expected to change the way disease is treated, but the price begs the question: Could Royals even have afforded it?

 

Ready, set, shop! About two-thirds of American holiday shoppers – and the National Retail Federation (NRF) anticipate that number will be more than 166 million this year – planned to shop in brick-and-mortar to stores over Thanksgiving weekend. More than a third were planning to go online on Cyber Monday. The NRF estimates sales will be up 6 percent to 8 percent over November and December. It remains to be seen how holiday deals will affect companies’ profits.

 

Pandemic redux. The number of daily COVID-19 cases in China reached a record high last week, affecting the cities of Beijing, Chongqing and Guangzhou. “Cities are once again expanding their testing efforts and building makeshift hospitals to quarantine the growing number of people who are infected. Though no city-wide lockdowns have been announced, the widespread restrictions are increasingly paralyzing economic activities, even as authorities pledge to make their responses more targeted and less disruptive,” reported Bloomberg News.

 

We hope you stay healthy and achieve all your shopping goals during the holidays! 

 

Weekly Focus – Think About It

“Never be limited by other people's limited imaginations. If you adopt their attitudes, then the possibility won't exist because you'll have already shut it out...You can hear other people's wisdom, but you've got to re-evaluate the world for yourself.”

—Mae C. Jemison, astronaut


Best regards,

Cimarron Wealth Management

 

P.S.  Please feel free to forward this commentary to family, friends, or colleagues. If you would like us to add them to the list, please reply to this email with their email address and we will ask for their permission to be added.

 

Securities offered through LPL Financial, A Registered Investment Advisor, Member FINRA/SIPC. Investment advice offered through Cimarron Wealth Management, Inc., a registered investment advisor. Cimarron Wealth Management, Inc. is a separate entity from LPL Financial.

* These views are those of Carson Group Coaching, and not the presenting Representative or the Representative’s Broker/Dealer and should not be construed as investment advice.

 * This newsletter was prepared by Carson Group Coaching. Carson Group Coaching is not affiliated with the named broker/dealer.

* Government bonds and Treasury Bills are guaranteed by the U.S. government as to the timely payment of principal and interest and, if held to maturity, offer a fixed rate of return and fixed principal value. However, the value of fund shares is not guaranteed and will fluctuate.

*Corporate bonds are considered higher risk than government bonds but normally offer a higher yield and are subject to market, interest rate and credit risk as well as additional risks based on the quality of issuer coupon rate, price, yield, maturity, and redemption features.

* The Standard & Poor's 500 (S&P 500) is an unmanaged group of securities considered to be representative of the stock market in general. You cannot invest directly in this index.

* The Standard & Poor’s 500 (S&P 500) is an unmanaged index. Unmanaged index returns do not reflect fees, expenses, or sales charges. Index performance is not indicative of the performance of any investment.

* The 10-year Treasury Note represents debt owed by the United States Treasury to the public. Since the U.S. Government is seen as a risk-free borrower, investors use the 10-year Treasury Note as a benchmark for the long-term bond market.

* Gold represents the afternoon gold price as reported by the London Bullion Market Association. The gold price is set twice daily by the London Gold Fixing Company at 10:30 and 15:00 and is expressed in U.S. dollars per fine troy ounce.

* The Bloomberg Commodity Index is designed to be a highly liquid and diversified benchmark for the commodity futures market. The Index is composed of futures contracts on 19 physical commodities and was launched on July 14, 1998.

* The DJ Equity All REIT Total Return Index measures the total return performance of the equity subcategory of the Real Estate Investment Trust (REIT) industry as calculated by Dow Jones.

* Yahoo! Finance is the source for any reference to the performance of an index between two specific periods.

* Opinions expressed are subject to change without notice and are not intended as investment advice or to predict future performance.

* Economic forecasts set forth may not develop as predicted and there can be no guarantee that strategies promoted will be successful.

* Past performance does not guarantee future results. Investing involves risk, including loss of principal.

* You cannot invest directly in an index.

* Consult your financial professional before making any investment decision.

* Stock investing involves risk including loss of principal.

* To unsubscribe from the "Weekly Market Commentary" please write us at info@wealthwithapurpose.com.


Sources:

https://www.federalreserve.gov/monetarypolicy/files/fomcminutes20221102.pdf [Page 9]

https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html

https://www.bloomberg.com/news/articles/2022-11-23/us-economy-shows-signs-of-slowing-as-fed-hikes-filter-through (or go to https://resources.carsongroup.com/hubfs/WMC-Source/2022/11-28_22_Bloomberg_US%20Economy%20Shows%20Signs%20of%20Slowing_3.pdf)

https://www.barrons.com/market-data?mod=BOL_TOPNAV (or go to https://resources.carsongroup.com/hubfs/WMC-Source/2022/11-28-22_Barrons_DIJA_SP500_4.pdf)

https://home.treasury.gov/resource-center/data-chart-center/interest-rates/TextView?type=daily_treasury_yield_curve&field_tdr_date_value_month=202211

https://www.science.org/content/article/case-closed-famous-royals-suffered-hemophilia

https://www.cbsnews.com/news/fda-approves-hemgenix-most-expensive-drug-hemophilia-b/

https://nrf.com/media-center/press-releases/record-1663-million-shoppers-expected-during-thanksgiving-weekend

https://www.bloomberg.com/news/articles/2022-11-24/china-s-covid-cases-jump-to-a-record-as-outbreaks-persist (or go to https://resources.carsongroup.com/hubfs/WMC-Source/2022/11-28-22_Bloomberg_China%20Covid%20Cases%20Jump%20to%20Record%20High_9.pdf)

https://www.goodreads.com/quotes/144202-never-be-limited-by-other-people-s-limited-imaginations-if-you

Sign up for the Weekly Market Commentary

Thank you!
Oops!